Today: 20 May 2026
BitMine (BMNR) stock jumps 15% as Tom Lee presses 50‑billion authorized-share vote — what investors watch next
3 January 2026
2 mins read

BitMine (BMNR) stock jumps 15% as Tom Lee presses 50‑billion authorized-share vote — what investors watch next

NEW YORK, January 3, 2026, 11:15 ET — Market closed

  • BitMine shares closed up 14.9% Friday at $31.19 after new SEC-filed stockholder materials
  • Company is seeking approval to lift authorized shares to 50 billion from 500 million ahead of a Jan. 15 meeting
  • Traders now focus on the Jan. 14 voting deadline, crypto prices and next week’s U.S. data slate

BitMine Immersion Technologies, Inc. shares jumped 14.9% on Friday, ending at $31.19, after the crypto-focused company stepped up its push for shareholders to approve a sharp increase in the number of shares it is authorized to issue.

The vote matters because “authorized shares” set the legal ceiling on how much stock a company can issue under its charter — a key constraint for fundraising, acquisitions and stock splits. BitMine is asking investors to approve a charter amendment that would raise that limit to 50 billion shares from 500 million. SEC

For a stock that has traded with high volatility, the outcome could quickly change the company’s room to maneuver in capital markets. It also lands as BitMine highlights an Ethereum-focused treasury strategy, where it holds crypto assets on its balance sheet.

The stock was little changed in after-hours trading, last indicated around $31.45, after ranging between $27.46 and $31.26 in the regular session, according to Investing.com data.

In a Form 8-K filing dated Jan. 2, BitMine said it published an investor presentation, released a video of that presentation with a transcript, and posted related communications on social media tied to the charter amendment proposal ahead of its annual stockholder meeting.

“The most important reason we need to increase the authorized shares is we have to accommodate share splits,” Chairman Tom Lee said, according to a transcript included with the filing. SEC

In the same materials, Lee stressed the authorization request does not mean the company plans to issue 50 billion shares immediately; it expands the maximum that could be issued, including after any future splits.

BitMine said the proposal would give it flexibility for capital-markets activity — including at-the-market offerings, where companies sell stock into the market in small amounts over time — as well as potential mergers and acquisitions. It also cited the need for headroom to execute stock splits if the share price rises.

The company said it has seen its share price closely track ether since it pivoted in July to make Ethereum its primary treasury asset. Ether was last around $3,101, while bitcoin hovered near $89,956, according to market data.

Crypto-linked equities also rallied on Friday. Marathon Digital gained about 10%, Riot Platforms rose nearly 12% and CleanSpark climbed about 14%, according to market data.

Before next session, investors will focus on the shareholder-vote clock. BitMine set a Jan. 14, 11:59 p.m. ET deadline for votes ahead of its Jan. 15 annual meeting in Las Vegas, according to a company release.

Macro data will be another driver for risk appetite in high-beta names tied to crypto prices. A Reuters “week ahead” report said the U.S. employment report due Jan. 9 and the consumer price index on Jan. 13 are among the key releases as 2026 gets underway. The Economic Times

Technically, the stock’s first near-term test is Friday’s $31.26 intraday high and the $31.45 area after hours; a clean break above that range would leave round-number levels in focus for momentum traders. Support sits near $27.46 — Friday’s low — and around the prior close near $27.15.

One open question is timing around fundamentals: Nasdaq’s earnings page for BMNR showed no earnings announcement date available as of Jan. 1.

For longer-horizon investors, the bigger issue is what BitMine does with added authorization if shareholders approve it — whether it prioritizes a split, raises capital, or pursues deals — and how tightly the stock continues to trade with ether’s moves.

Stock Market Today

  • Sea Limited (NYSE:SE) Valuation Under Scrutiny After 46% One-Year Share Decline
    May 20, 2026, 10:05 AM EDT. Sea Limited (NYSE:SE), active across e-commerce, digital financial services, and digital entertainment in Southeast Asia and Latin America, has seen its stock fall by 46.26% over the past year. Despite recent share price weakness, some analysts argue the stock trades 36.6% below a $137.64 fair value estimate, buoyed by strong revenue growth from Shopee, Monee, and Garena platforms. Key drivers include accelerating mobile internet penetration, youth digital literacy, and shifts toward cashless payments supporting loan book expansion and improved monetization. Market watchers debate whether this dip offers a buying opportunity or reflects tempered growth prospects, especially as Shopee faces competitive pressures. Investors should weigh Sea's potential for earnings growth against market realities and execution risks.

Latest articles

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
Venezuela strikes ripple to St Maarten: SXM flights canceled, airlines issue travel waivers
Previous Story

Venezuela strikes ripple to St Maarten: SXM flights canceled, airlines issue travel waivers

Quantum computing stocks surge to start 2026: D-Wave, Rigetti, IonQ lead — what investors watch next
Next Story

Quantum computing stocks surge to start 2026: D-Wave, Rigetti, IonQ lead — what investors watch next

Go toTop